| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/13/2010 | US20100119538 Chimeric osteogenic factor containing proteins capable of increased nuclear localization and methods of use thereof |
| 05/13/2010 | US20100119537 Tumor vaccine |
| 05/13/2010 | US20100119536 Naturally Processed Measles Virus Peptides From Class II HLA Molecules |
| 05/13/2010 | US20100119535 Compositions and methods for immunodominant antigens |
| 05/13/2010 | US20100119534 Multicomponent immunogenic composition for the prevention of beta-hemolytic streptococcal (bhs) disease |
| 05/13/2010 | US20100119533 Polynucleotides and Polypeptides Identified by IVIAT Screening and Methods of Use |
| 05/13/2010 | US20100119532 Composition comprising the N-terminal region of histone H2B of Leishmania - use thereof for inducing an immune response |
| 05/13/2010 | US20100119531 Nutriceutical gels |
| 05/13/2010 | US20100119530 Regulation of TLR Signaling by Complement |
| 05/13/2010 | US20100119529 Elastin-like polymer delivery vehicles |
| 05/13/2010 | US20100119528 Transport of Biologically Active Molecules into a Cell, Mitochondrion, or Nucleus |
| 05/13/2010 | US20100119527 N-cadherin: target for cancer diagnosis and therapy |
| 05/13/2010 | US20100119526 DLL4 Signaling Inhibitors and Uses Thereof |
| 05/13/2010 | US20100119525 Method for extending longevity using npc1l1 antagonists |
| 05/13/2010 | US20100119524 Adjuvanted vaccine |
| 05/13/2010 | US20100119523 Vascular endothelial cell growth factor antagonists |
| 05/13/2010 | US20100119522 Combination therapy for the treatment of ocular neovascular disorders |
| 05/13/2010 | US20100119521 Compositions and methods for treating cancer by modulating her-2 and egf receptors |
| 05/13/2010 | US20100119520 Monoclonal antibodies that neutralize anthrax toxins |
| 05/13/2010 | US20100119519 Ophthalmic drug delivery system and method |
| 05/13/2010 | US20100119518 Target for breast cancer therapy and/or diagnosis |
| 05/13/2010 | US20100119517 Use of Anti-MAdCAM Antibodies for the Treatment of Coeliac Disease and Tropical Sprue |
| 05/13/2010 | US20100119516 Anti-tgf-beta receptor ii antibodies |
| 05/13/2010 | US20100119515 Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors |
| 05/13/2010 | US20100119514 Antibodies Against Cancer |
| 05/13/2010 | US20100119513 Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof |
| 05/13/2010 | US20100119512 Methods of diagnosing, treating, and preventing increased vascular permeability |
| 05/13/2010 | US20100119511 Light targeting molecules and uses thereof |
| 05/13/2010 | US20100119510 Lactam-containing compounds and derivatives thereof as factor xa inhibitors |
| 05/13/2010 | US20100119509 Polynucleotides and polypeptides associated with the development of rheumatoid arthritis |
| 05/13/2010 | US20100119508 Phenylacetic acid inhibitors of cyclooxygenase |
| 05/13/2010 | US20100119507 Streptococcus pyogenes antigens and corresponding dna fragments |
| 05/13/2010 | US20100119506 Effectors of PAR-2 Activation and Their Use in the Modulation of Inflammation |
| 05/13/2010 | US20100119505 Estrogen Related Receptor, ERRalpha, A Regulator of Bone Formation |
| 05/13/2010 | US20100119504 Marker Sequences for Labour |
| 05/13/2010 | US20100119503 3-aminocyclopentanecarboxamides as modulators of chemokine receptors |
| 05/13/2010 | US20100119483 Peptide viral entry inhibitors |
| 05/13/2010 | US20100119482 Treatment of Conditions Through Modulation of the Autonomic Nervous System During at Least One Predetermined Menstrual Cycle Phase |
| 05/13/2010 | US20100119480 Methods for treating multiple sclerosis using antisense oligonucleotides |
| 05/13/2010 | US20100119478 ANTIBODIES DIRECTED AGAINST PYROGLUTAMATE MONOCYTE CHEMOATTRACTANT PROTEIN-1 (MCP-1 N1pE) |
| 05/13/2010 | US20100119477 Psm peptides as vaccine targets against methicillin-resistant staphylococcus |
| 05/13/2010 | US20100119475 Novel inhibitors of glutaminyl cyclase |
| 05/13/2010 | US20100119471 Mycoplasma hyopneumoniae bacterin vaccine |
| 05/13/2010 | US20100119446 Specific and high affinity binding proteins comprising modified sh3 domains of fyn kinase |
| 05/13/2010 | US20100119445 Plexin d1 as a target for tumor diagnosis and therapy |
| 05/12/2010 | EP2184607A1 Immune response assessment method |
| 05/12/2010 | EP2184298A1 Antibodies against human IL-21 receptor and uses therefor |
| 05/12/2010 | EP2184296A1 Fibroblast growth factor (fgf23) and methods for use |
| 05/12/2010 | EP2184085A1 Treatment of diseases |
| 05/12/2010 | EP2184072A1 Production of an homogeneous vaccine preparation for cancer treatment |
| 05/12/2010 | EP2184071A1 Capsular polysaccharide solubilisation and combination vaccines |
| 05/12/2010 | EP2184067A1 Severe acute respiratory syndrome DNA vaccine compositions and methods of use |
| 05/12/2010 | EP2183597A1 Immunogenic streptococcus proteins |
| 05/12/2010 | EP2183366A1 Immunogenic polypeptides and monoclonal antibodies |
| 05/12/2010 | EP2183361A1 Novel immunotherapy against neuronal and brain tumors |
| 05/12/2010 | EP2183281A1 LOCAL ADMINISTRATION OF CHICKEN YOLK IMMUNE GLOBULINS (IgY) TO TREAT AND PREVENT FUNGAL INFECTIONS |
| 05/12/2010 | EP2183278A2 Novel immunogenic epitopes for immunotherapy |
| 05/12/2010 | EP2183028A2 Targeted binging agents directed to kdr and uses thereof - 035 |
| 05/12/2010 | EP2182983A1 Treatment of amyloidogenic diseases |
| 05/12/2010 | EP2182982A2 Therapeutic use of anti-tweak receptor antibodies |
| 05/12/2010 | EP2182981A2 Methods and compositions for treatment and diagnosis of fibrosis, tumor invasion, angiogenesis, and metastasis |
| 05/12/2010 | EP2182934A1 Uses of trientine and penicillamine as countermeasures to metal contamination |
| 05/12/2010 | EP2182922A1 Antigen-adjuvant compositions and methods |
| 05/12/2010 | EP1578772B1 Cytokines and cytokine receptors with reduced immunogenicity |
| 05/12/2010 | EP1578374B1 Escape mutants of newcastle disease virus as marker vaccines |
| 05/12/2010 | EP1436397B1 Hepatitis c virus vaccine |
| 05/12/2010 | CN1933853B Drug conjugates |
| 05/12/2010 | CN1903880B Antitumour vascular endothelial growth factor VEGF-E antigen, its coding gene and application |
| 05/12/2010 | CN1864746B Gene engineered poly-valence subunit vaccine of pylorus Hp AhpC-NapA and preparation method thereof |
| 05/12/2010 | CN1844151B Monoclonal antibody against human CD40 mutant molecule and its use |
| 05/12/2010 | CN1843506B Medicine containing bacillus tubercle vaccine |
| 05/12/2010 | CN1810961B Recombinant influenza virus and its preparation and application |
| 05/12/2010 | CN1809380B Polypeptide-vaccines for broad protection against hypervirulent meningococcal lineages |
| 05/12/2010 | CN1738901B Modular antigen transporter molecules (MAT molecules) for modulating immune reactions, associated constructs, methods and uses |
| 05/12/2010 | CN1738643B Composition and method for preventing or treating a virus infection |
| 05/12/2010 | CN1735431B Whole bacterial cells as immune modulator |
| 05/12/2010 | CN1731979B Allergen dosage form |
| 05/12/2010 | CN1644686B High yielded strain of mammalia influenza virus, its recommbined strains and preparation and use thereof |
| 05/12/2010 | CN1630663B Synthetic or natural peptides binding protein phosphatase 2A, identification method and uses |
| 05/12/2010 | CN1599750B Cytotoxic protein and utilization thereof |
| 05/12/2010 | CN1564867B DNA-expression construct for treatment of infections with leishmaniasis |
| 05/12/2010 | CN1426423B Humanized antibodies that sequester amyloid beta peptide |
| 05/12/2010 | CN1350578B Recombinant influenza viruses for vaccines and gene therapy |
| 05/12/2010 | CN101707918A Shigella ipad protein and its use as a vaccine against shigella infection |
| 05/12/2010 | CN101707882A Pdgfrss-specific inhibitors |
| 05/12/2010 | CN101705233A Recombinant human herpes simplex virus I protein HSV I gG and application thereof |
| 05/12/2010 | CN101705198A Edwardsiella tarda attenuated strain and application thereof |
| 05/12/2010 | CN101704892A Anti-uPAR humanized antibody, coding gene and application thereof |
| 05/12/2010 | CN101704891A Antibody for epidermal growth factor receptor, encoding gene thereof and application thereof |
| 05/12/2010 | CN101704870A Glutaryl cholesterol and liposome thereof and application of the liposome as vaccine adjuvant |
| 05/12/2010 | CN101703772A Compound indigowoad root oral liquid for improving poultry immunity and preparation method thereof |
| 05/12/2010 | CN101703771A Oil-in-water type compound vaccine adjuvant and method for preparing same |
| 05/12/2010 | CN101703770A Polyvalent DNA vaccine in ovo |
| 05/12/2010 | CN101703769A Novel tetravalent inactivated vaccine for streptococcus suis disease |
| 05/12/2010 | CN101703768A Preparation method of vibrio parahaemolyticus outer membrane protein VP1061 and application of immunity protective function thereof |
| 05/12/2010 | CN101703767A Preparation method of nibrio parahaemolyticus outer membrane protein VP2850and application of immunity protective function thereof |
| 05/12/2010 | CN101703766A Oil-adjuvant vaccine of larvae membrane protein of cryptocaryon irritans, preparation method and applications thereof |
| 05/12/2010 | CN101481415B Novel PRRS virus receptor and block inhibitor thereof |
| 05/12/2010 | CN101234197B Recombination attenuation salmonella typhimurium vector vaccine and preparation |
| 05/12/2010 | CN101130090B Application of BRSK2 in producing antidiabetic medicine |